Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 357165, 8 pages
http://dx.doi.org/10.1155/2015/357165
Clinical Study

Cushing’s Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation

1Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Ul. Szaserów 128, 04-141 Warsaw, Poland
2Department of Neurosurgery, Military Institute of Medicine, Ul. Szaserów 128, 04-141 Warsaw, Poland
3Department of Epidemiology, Institute of Mother and Child, Ul. Kasprzaka 17a, 01-211 Warsaw, Poland

Received 6 April 2015; Revised 2 June 2015; Accepted 9 June 2015

Academic Editor: Elena Valassi

Copyright © 2015 Przemysław Witek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. K. Nieman, B. M. K. Biller, J. W. Findling et al., “The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Guignat and J. Bertherat, “The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline: commentary from a European perspective,” European Journal of Endocrinology, vol. 163, no. 1, pp. 9–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Zada, “Diagnosis and multimodality management of Cushing's disease: a practical review,” International Journal of Endocrinology, vol. 2013, Article ID 893781, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Witek, G. Zieliński, M. Maksymowicz, and G. Kamiński, “Cushing's disease—assessing the efficacy of transsphenoidal surgery,” Endokrynologia Polska, vol. 63, no. 5, pp. 398–404, 2012. View at Google Scholar · View at Scopus
  5. S.-C. Tung, P.-W. Wang, R.-T. Liu et al., “Clinical characteristics of endogenous Cushing's syndrome at a medical center in Southern Taiwan,” International Journal of Endocrinology, vol. 2013, Article ID 685375, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. G. Patil, D. M. Prevedello, S. P. Lad et al., “Late recurrences of Cushing's disease after initial successful transsphenoidal surgery,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 2, pp. 358–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Losa, R. Bianchi, R. Barzaghi, M. Giovanelli, and P. Mortini, “Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3322–3328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Losa, P. Mortini, S. Dylgjeri et al., “Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease,” Clinical Endocrinology, vol. 55, no. 1, pp. 61–68, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Castinetti, M. Martinie, I. Morange et al., “A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 6, pp. 1897–1903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Witek, W. Zgliczyński, G. Zieliński, and W. Jeske, “The role of combined low-dose dexamethasone suppression test and desmopressin stimulation test in the diagnosis of persistent Cushing's disease. Case report,” Endokrynologia Polska, vol. 61, no. 3, pp. 312–317, 2010. View at Google Scholar · View at Scopus
  11. P. Colombo, E. Passini, T. Re, G. Faglia, and B. Ambrosi, “Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess,” Clinical Endocrinology, vol. 46, no. 6, pp. 661–668, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. de Keyzer, P. René, C. Beldjord, F. Lenne, and X. Bertagna, “Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours,” Clinical Endocrinology, vol. 49, no. 4, pp. 475–482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Moro, P. Putignano, M. Losa, C. Invitti, C. Maraschini, and F. Cavagnini, “The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 10, pp. 3569–3574, 2000. View at Google Scholar · View at Scopus
  14. F. P. Giraldi, R. Pivonello, A. G. Ambrogio et al., “The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states,” Clinical Endocrinology, vol. 66, no. 2, pp. 251–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Tirabassi, E. Faloia, R. Papa, G. Furlani, M. Boscaro, and G. Arnaldi, “Use of the desmopressin test in the differential diagnosis of pseudo-cushing state from cushing's disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 3, pp. 1115–1122, 2010. View at Publisher · View at Google Scholar · View at Scopus